ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Recombinant Collagen-Based Biomaterial Market Outlook, In‑Depth Analysis & Forecast to 2031
Published Date: October 2025
|
Report Code: QYRE-Auto-32S17346
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Recombinant Collagen Based Biomaterial Market Research Report 2024
BUY CHAPTERS

Global Recombinant Collagen-Based Biomaterial Market Outlook, In‑Depth Analysis & Forecast to 2031

Code: QYRE-Auto-32S17346
Report
October 2025
Pages:136
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Evonik Industries
TRAUTEC
FibroGen Inc
CollPlant
Geltor
Modern Meadow
Genemedicine

Recombinant Collagen-Based Biomaterial Market

The global Recombinant Collagen-Based Biomaterial market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Recombinant collagen-based biomaterials are collagen produced by biotechnology, usually synthesized in microorganisms or plant cells using recombinant DNA technology. Compared with traditional animal-derived collagen, recombinant collagen has higher purity and consistency, does not contain animal pathogens, and reduces the risk of immune response. It is widely used in the fields of medicine, pharmaceuticals, cosmetics, food and bioprinting, providing excellent biocompatibility and functional diversity, and promoting the development of tissue repair, wound healing, skin care and anti-aging, nutritional supplements and tissue engineering.
Recombinant collagen-based biomaterials are produced through biotechnology, with advantages such as high purity, good quality consistency, and no animal pathogens, which greatly reduces the risk of immune response. This material shows broad application prospects in the fields of medicine, pharmaceuticals, cosmetics, food, and bioprinting. In medicine, recombinant collagen is used in tissue engineering and wound repair to promote tissue regeneration and healing; in the cosmetic field, it has become an important ingredient in skin care products due to its excellent moisturizing and anti-aging properties; in food and nutritional supplements, recombinant collagen provides health and beauty benefits and supports joint and skin health. In addition, recombinant collagen is used in 3D bioprinting technology to help build complex biological structures and develop tissue engineering. The versatility and safety of this material make it a key factor in promoting innovation and development in multiple industries.

Report Includes:

This definitive report equips CEOs, marketing directors, and investors with a 360° view of the global Recombinant Collagen-Based Biomaterial market, seamlessly integrating production capacity and sales performance across the value chain. It analyzes historical production, revenue, and sales data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies volume and value, growth rates, technical innovations, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries. Each region’s dominant products, competitive landscape, and downstream demand trends are clearly detailed.
Critical competitive intelligence profiles manufacturers—capacity, sales volume, revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise supply‑chain overview maps upstream suppliers, manufacturing technologies, cost structures, and distribution dynamics to identify strategic gaps and unmet demand.
Market Segmentation

Scope of Recombinant Collagen-Based Biomaterial Market Report

Report Metric Details
Report Name Recombinant Collagen-Based Biomaterial Market
Segment by Type
Segment by Application
  • Medical Industry
  • Cosmetic Industry
  • Food Industry
  • Others
Production by Region
  • North America
  • Europe
  • China
  • Japan
Sales by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Evonik Industries, Trautec, Genemedicine, FibroGen, CollPlant, Geltor, Modern Meadow
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the Recombinant Collagen-Based Biomaterial study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
  • Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
  • Chapter 3: Maps global production capacity, utilization, and market share (2020–2031), identifies efficient hubs, reveals regulatory/trade policy impacts and bottlenecks.
  • Chapter 4: Dissects the manufacturer landscape—ranks by volume and revenue, analyzes profitability and pricing, maps production bases, details manufacturer performance by product type and evaluates concentration alongside M&A moves.
  • Chapter 5: Unlocks high margin product segments—compares sales, revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
  • Chapter 6: Targets downstream market opportunities—evaluates sales, revenue, and pricing by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
  • Chapter 7: North America—breaks down sales and revenue by Type, by Application and country, profiles key manufacturers and assesses growth drivers and barriers.
  • Chapter 8: Europe—analyses regional sales, revenue and market by Type, by Application and manufacturers, flagging drivers and barriers.
  • Chapter 9: Asia Pacific—quantifies sales and revenue by Type, by Application, and region/country, profiles top manufacturers, and uncovers high potential expansion areas.
  • Chapter 10: Central & South America—measures sales and revenue by Type, by Application, and country, profiles top manufacturers, and identifies investment opportunities and challenges.
  • Chapter 11: Middle East and Africa—evaluates sales and revenue by Type, by Application, and country, profiles key manufacturers, and outlines investment prospects and market hurdles
  • Chapter 12: Profiles manufacturers in depth—details product specs, capacity, sales, revenue, margins; Top manufactures 2024 sales breakdowns by Product type, by Application, by sales region SWOT analysis, and recent strategic developments.
  • Chapter 13: Supply chain—analyses upstream raw materials and suppliers, manufacturing footprint and technology, cost drivers, plus downstream channels and distributor roles.
  • Chapter 14: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
  • Chapter 15: Actionable conclusions and strategic recommendations.
  • Why This Report:
  • Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
  • Allocate capital strategically to high growth regions (Chapters 7–11) and margin rich segments (Chapter 5).
  • Negotiate from strength with suppliers (Chapter 13) and customers (Chapter 6) using cost and demand intelligence.
  • Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 4 and 12).
  • Secure your supply chain against disruptions through upstream and downstream visibility (Chapters 13 and 14).
  • Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.

FAQ for this report

Who are the main players in the Recombinant Collagen-Based Biomaterial Market report?

Ans: The main players in the Recombinant Collagen-Based Biomaterial Market are Evonik Industries, Trautec, Genemedicine, FibroGen, CollPlant, Geltor, Modern Meadow

What are the Application segmentation covered in the Recombinant Collagen-Based Biomaterial Market report?

Ans: The Applications covered in the Recombinant Collagen-Based Biomaterial Market report are Medical Industry, Cosmetic Industry, Food Industry, Others

What are the Type segmentation covered in the Recombinant Collagen-Based Biomaterial Market report?

Ans: The Types covered in the Recombinant Collagen-Based Biomaterial Market report are Medical Grade Recombinant Collagen, Cosmetic Grade Recombinant Collagen, Food Grade Recombinant Collagen, Others

Recommended Reports

Medical Collagen Use

Alternative Collagen Sources

Biomaterials & Supplements

1 Study Coverage
1.1 Introduction to Recombinant Collagen-Based Biomaterial: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Recombinant Collagen-Based Biomaterial Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Medical Grade Recombinant Collagen
1.2.3 Cosmetic Grade Recombinant Collagen
1.2.4 Food Grade Recombinant Collagen
1.2.5 Others
1.3 Market Segmentation by Application
1.3.1 Global Recombinant Collagen-Based Biomaterial Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Medical Industry
1.3.3 Cosmetic Industry
1.3.4 Food Industry
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Recombinant Collagen-Based Biomaterial Revenue Estimates and Forecasts 2020-2031
2.2 Global Recombinant Collagen-Based Biomaterial Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020--2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.3 Global Recombinant Collagen-Based Biomaterial Sales Estimates and Forecasts 2020-2031
2.4 Global Recombinant Collagen-Based Biomaterial Sales by Region
2.4.1 Sales Comparison: 2020 VS 2024 VS 2031
2.4.2 Historical and Forecasted Sales by Region (2020-2031)
2.4.3 Emerging Market Focus: Growth Drivers & Investment Trends
2.4.4 Global Sales Market Share by Region (2020-2031)
3 Global Production Analysis
3.1 Global Recombinant Collagen-Based Biomaterial Production Capacity and Utilization Rates (2020–2031)
3.2 Regional Production: Comparative Analysis (2020 VS 2024 VS 2031)
3.3 Regional Production Dynamics
3.3.1 Historic Production by Region (2020-2025)
3.3.2 Forecasted Production by Region (2026-2031)
3.3.3 Production Market Share by Region (2020-2031)
3.3.4 Regulatory and Trade Policy Impact on Production
3.3.5 Production Capacity Enablers and Constraints
3.4 Key Regional Production Hubs
3.4.1 North America
3.4.2 Europe
3.4.3 China
3.4.4 Japan
4 Competition by Manufacturers
4.1 Global Recombinant Collagen-Based Biomaterial Sales by Manufacturers
4.1.1 Global Sales Volume by Manufacturers (2020-2025)
4.1.2 Global Top 5 and Top 10 Manufacturers’Market Share by Sales Volume (2024)
4.2 Global Recombinant Collagen-Based Biomaterial Manufacturer Revenue Rankings and Tiers
4.2.1 Global Revenue (Value) by Manufacturers (2020-2025)
4.2.2 Global Key Manufacturer Revenue Ranking (2023 vs. 2024)
4.2.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
4.3 Manufacturer Profitability Profiles and Pricing Strategies
4.3.1 Gross Margin by Top Manufacturer (2020 VS 2024)
4.3.2 Manufacturer-Level Price Trends (2020-2025)
4.4 Key Manufacturers Manufacturing Base and Headquarters
4.5 Main Product Type Market Size by Manufacturers
4.5.1 Medical Grade Recombinant Collagen Market Size by Manufacturers
4.5.2 Cosmetic Grade Recombinant Collagen Market Size by Manufacturers
4.5.3 Food Grade Recombinant Collagen Market Size by Manufacturers
4.5.4 Others Market Size by Manufacturers
4.6 Global Recombinant Collagen-Based Biomaterial Market Concentration and Dynamics
4.6.1 Global Market Concentration (CR5 and HHI)
4.6.2 Entrant/Exit Impact Analysis
4.6.3 Strategic Moves: M&A, Capacity Expansion, R&D Investment
5 Global Product Segmentation Analysis
5.1 Global Recombinant Collagen-Based Biomaterial Sales Performance by Type
5.1.1 Global Historical and Forecasted Sales by Type (2020-2031)
5.1.2 Global Sales Market Share by Type (2020-2031)
5.2 Global Recombinant Collagen-Based Biomaterial Revenue Trends by Type
5.2.1 Global Historical and Forecasted Revenue by Type (2020-2031)
5.2.2 Global Revenue Market Share by Type (2020-2031)
5.3 Global Average Selling Price (ASP) Trends by Type (2020-2031)
5.4 Product Technology Differentiation
5.5 Subtype Dynamics: Growth Leaders, Profitability and Risk
5.5.1 High-Growth Niches and Adoption Drivers
5.5.2 Profitability Hotspots and Cost Drivers
5.5.3 Substitution Threats
6 Global Downstream Application Analysis
6.1 Global Recombinant Collagen-Based Biomaterial Sales by Application
6.1.1 Global Historical and Forecasted Sales by Application (2020-2031)
6.1.2 Global Sales Market Share by Application (2020-2031)
6.1.3 High-Growth Application Identification
6.1.4 Emerging Application Case Studies
6.2 Global Recombinant Collagen-Based Biomaterial Revenue by Application
6.2.1 Global Historical and Forecasted Revenue by Application (2020-2031)
6.2.2 Revenue Market Share by Application (2020-2031)
6.3 Global Pricing Dynamics by Application (2020-2031)
6.4 Downstream Customer Analysis
6.4.1 Top Customers by Region
6.4.2 Top Customers by Application
7 North America
7.1 North America Sales Volume and Revenue (2020-2031)
7.2 North America Key Manufacturers Sales Revenue in 2024
7.3 North America Recombinant Collagen-Based Biomaterial Sales and Revenue by Type (2020-2031)
7.4 North America Recombinant Collagen-Based Biomaterial Sales and Revenue by Application (2020-2031)
7.5 North America Growth Accelerators and Market Barriers
7.6 North America Recombinant Collagen-Based Biomaterial Market Size by Country
7.6.1 North America Revenue by Country
7.6.2 North America Sales Trends by Country
7.6.3 US
7.6.4 Canada
7.6.5 Mexico
8 Europe
8.1 Europe Sales Volume and Revenue (2020-2031)
8.2 Europe Key Manufacturers Sales Revenue in 2024
8.3 Europe Recombinant Collagen-Based Biomaterial Sales and Revenue by Type (2020-2031)
8.4 Europe Recombinant Collagen-Based Biomaterial Sales and Revenue by Application (2020-2031)
8.5 Europe Growth Accelerators and Market Barriers
8.6 Europe Recombinant Collagen-Based Biomaterial Market Size by Country
8.6.1 Europe Revenue by Country
8.6.2 Europe Sales Trends by Country
8.6.3 Germany
8.6.4 France
8.6.5 U.K.
8.6.6 Italy
8.6.7 Russia
9 Asia-Pacific
9.1 Asia-Pacific Sales Volume and Revenue (2020-2031)
9.2 Asia-Pacific Key Manufacturers Sales Revenue in 2024
9.3 Asia-Pacific Recombinant Collagen-Based Biomaterial Sales and Revenue by Type (2020-2031)
9.4 Asia-Pacific Recombinant Collagen-Based Biomaterial Sales and Revenue by Application (2020-2031)
9.5 Asia-Pacific Recombinant Collagen-Based Biomaterial Market Size by Region
9.5.1 Asia-Pacific Revenue by Region
9.5.2 Asia-Pacific Sales Trends by Region
9.6 Asia-Pacific Growth Accelerators and Market Barriers
9.7 Southeast Asia
9.7.1 Southeast Asia Revenue by Country (2020 VS 2024 VS 2031)
9.7.2 Key Country Analysis: Indonesia, Vietnam, Thailand
9.8 China
9.9 Japan
9.10 South Korea
9.11 China Taiwan
9.12 India
10 Central and South America
10.1 Central and South America Sales Volume and Revenue (2020-2031)
10.2 Central and South America Key Manufacturers Sales Revenue in 2024
10.3 Central and South America Recombinant Collagen-Based Biomaterial Sales and Revenue by Type (2020-2031)
10.4 Central and South America Recombinant Collagen-Based Biomaterial Sales and Revenue by Application (2020-2031)
10.5 Central and South America Investment Opportunities and Key Challenges
10.6 Central and South America Recombinant Collagen-Based Biomaterial Market Size by Country
10.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 Brazil
10.6.3 Argentina
11 Middle East and Africa
11.1 Middle East and Africa Sales Volume and Revenue (2020-2031)
11.2 Middle East and Africa Key Manufacturers Sales Revenue in 2024
11.3 Middle East and Africa Recombinant Collagen-Based Biomaterial Sales and Revenue by Type (2020-2031)
11.4 Middle East and Africa Recombinant Collagen-Based Biomaterial Sales and Revenue by Application (2020-2031)
11.5 Middle East and Africa Investment Opportunities and Key Challenges
11.6 Middle East and Africa Recombinant Collagen-Based Biomaterial Market Size by Country
11.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
11.6.2 GCC Countries
11.6.3 Turkey
11.6.4 Egypt
11.6.5 South Africa
12 Corporate Profile
12.1 Evonik Industries
12.1.1 Evonik Industries Corporation Information
12.1.2 Evonik Industries Business Overview
12.1.3 Evonik Industries Recombinant Collagen-Based Biomaterial Product Models, Descriptions and Specifications
12.1.4 Evonik Industries Recombinant Collagen-Based Biomaterial Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.1.5 Evonik Industries Recombinant Collagen-Based Biomaterial Sales by Product in 2024
12.1.6 Evonik Industries Recombinant Collagen-Based Biomaterial Sales by Application in 2024
12.1.7 Evonik Industries Recombinant Collagen-Based Biomaterial Sales by Geographic Area in 2024
12.1.8 Evonik Industries Recombinant Collagen-Based Biomaterial SWOT Analysis
12.1.9 Evonik Industries Recent Developments
12.2 Trautec
12.2.1 Trautec Corporation Information
12.2.2 Trautec Business Overview
12.2.3 Trautec Recombinant Collagen-Based Biomaterial Product Models, Descriptions and Specifications
12.2.4 Trautec Recombinant Collagen-Based Biomaterial Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.2.5 Trautec Recombinant Collagen-Based Biomaterial Sales by Product in 2024
12.2.6 Trautec Recombinant Collagen-Based Biomaterial Sales by Application in 2024
12.2.7 Trautec Recombinant Collagen-Based Biomaterial Sales by Geographic Area in 2024
12.2.8 Trautec Recombinant Collagen-Based Biomaterial SWOT Analysis
12.2.9 Trautec Recent Developments
12.3 Genemedicine
12.3.1 Genemedicine Corporation Information
12.3.2 Genemedicine Business Overview
12.3.3 Genemedicine Recombinant Collagen-Based Biomaterial Product Models, Descriptions and Specifications
12.3.4 Genemedicine Recombinant Collagen-Based Biomaterial Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.3.5 Genemedicine Recombinant Collagen-Based Biomaterial Sales by Product in 2024
12.3.6 Genemedicine Recombinant Collagen-Based Biomaterial Sales by Application in 2024
12.3.7 Genemedicine Recombinant Collagen-Based Biomaterial Sales by Geographic Area in 2024
12.3.8 Genemedicine Recombinant Collagen-Based Biomaterial SWOT Analysis
12.3.9 Genemedicine Recent Developments
12.4 FibroGen
12.4.1 FibroGen Corporation Information
12.4.2 FibroGen Business Overview
12.4.3 FibroGen Recombinant Collagen-Based Biomaterial Product Models, Descriptions and Specifications
12.4.4 FibroGen Recombinant Collagen-Based Biomaterial Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.4.5 FibroGen Recombinant Collagen-Based Biomaterial Sales by Product in 2024
12.4.6 FibroGen Recombinant Collagen-Based Biomaterial Sales by Application in 2024
12.4.7 FibroGen Recombinant Collagen-Based Biomaterial Sales by Geographic Area in 2024
12.4.8 FibroGen Recombinant Collagen-Based Biomaterial SWOT Analysis
12.4.9 FibroGen Recent Developments
12.5 CollPlant
12.5.1 CollPlant Corporation Information
12.5.2 CollPlant Business Overview
12.5.3 CollPlant Recombinant Collagen-Based Biomaterial Product Models, Descriptions and Specifications
12.5.4 CollPlant Recombinant Collagen-Based Biomaterial Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.5.5 CollPlant Recombinant Collagen-Based Biomaterial Sales by Product in 2024
12.5.6 CollPlant Recombinant Collagen-Based Biomaterial Sales by Application in 2024
12.5.7 CollPlant Recombinant Collagen-Based Biomaterial Sales by Geographic Area in 2024
12.5.8 CollPlant Recombinant Collagen-Based Biomaterial SWOT Analysis
12.5.9 CollPlant Recent Developments
12.6 Geltor
12.6.1 Geltor Corporation Information
12.6.2 Geltor Business Overview
12.6.3 Geltor Recombinant Collagen-Based Biomaterial Product Models, Descriptions and Specifications
12.6.4 Geltor Recombinant Collagen-Based Biomaterial Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.6.5 Geltor Recent Developments
12.7 Modern Meadow
12.7.1 Modern Meadow Corporation Information
12.7.2 Modern Meadow Business Overview
12.7.3 Modern Meadow Recombinant Collagen-Based Biomaterial Product Models, Descriptions and Specifications
12.7.4 Modern Meadow Recombinant Collagen-Based Biomaterial Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.7.5 Modern Meadow Recent Developments
13 Value Chain and Supply-Chain Analysis
13.1 Recombinant Collagen-Based Biomaterial Industry Chain
13.2 Recombinant Collagen-Based Biomaterial Upstream Materials Analysis
13.2.1 Raw Materials
13.2.2 Key Suppliers Market Share & Risk Assessment
13.3 Recombinant Collagen-Based Biomaterial Integrated Production Analysis
13.3.1 Manufacturing Footprint Analysis
13.3.2 Production Technology Overview
13.3.3 Regional Cost Drivers
13.4 Recombinant Collagen-Based Biomaterial Sales Channels and Distribution Networks
13.4.1 Sales Channels
13.4.2 Distributors
14 Recombinant Collagen-Based Biomaterial Market Dynamics
14.1 Industry Trends and Evolution
14.2 Market Growth Drivers and Emerging Opportunities
14.3 Market Challenges, Risks, and Restraints
15 Key Findings in the Global Recombinant Collagen-Based Biomaterial Study
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.1.1 Research Programs/Design
16.1.1.2 Market Size Estimation
16.1.1.3 Market Breakdown and Data Triangulation
16.1.2 Data Source
16.1.2.1 Secondary Sources
16.1.2.2 Primary Sources
16.2 Author Details
FEATURED COMPANIES
Evonik Industries
TRAUTEC
FibroGen Inc
CollPlant
Geltor
Modern Meadow
Genemedicine
List of Tables
 Table 1. Global Recombinant Collagen-Based Biomaterial Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
 Table 2. Global Recombinant Collagen-Based Biomaterial Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
 Table 3. Global Recombinant Collagen-Based Biomaterial Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 4. Global Recombinant Collagen-Based Biomaterial Revenue by Region (2020-2025) & (US$ Million)
 Table 5. Global Recombinant Collagen-Based Biomaterial Revenue by Region (2026-2031) & (US$ Million)
 Table 6. Global Recombinant Collagen-Based Biomaterial Sales Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (Tons)
 Table 7. Global Recombinant Collagen-Based Biomaterial Sales by Region (2020-2025) & (Tons)
 Table 8. Global Recombinant Collagen-Based Biomaterial Sales by Region (2026-2031) & (Tons)
 Table 9. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 10. Global Recombinant Collagen-Based Biomaterial Production Growth Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (Tons)
 Table 11. Global Recombinant Collagen-Based Biomaterial Production by Region (2020-2025) & (Tons)
 Table 12. Global Recombinant Collagen-Based Biomaterial Production by Region (2026-2031) & (Tons)
 Table 13. Global Recombinant Collagen-Based Biomaterial Sales by Manufacturers (2020-2025) & (Tons)
 Table 14. Global Recombinant Collagen-Based Biomaterial Sales Share by Manufacturers (2020-2025)
 Table 15. Global Recombinant Collagen-Based Biomaterial Revenue by Manufacturers (2020-2025) & (US$ Million)
 Table 16. Global Recombinant Collagen-Based Biomaterial Revenue Market Share by Manufacturers (2020-2025)
 Table 17. Global Key Manufacturers’Ranking Shift (2023 vs. 2024) (Based on Revenue)
 Table 18. Global Recombinant Collagen-Based Biomaterial by Manufacturer Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Recombinant Collagen-Based Biomaterial as of 2024)
 Table 19. Global Recombinant Collagen-Based Biomaterial Average Gross Margin (%) by Manufacturer (2020 VS 2024)
 Table 20. Global Recombinant Collagen-Based Biomaterial Average Selling Price (ASP) by Manufacturers (2020-2025) & (US$/Ton)
 Table 21. Key Manufacturers Recombinant Collagen-Based Biomaterial Manufacturing Base and Headquarters
 Table 22. Global Recombinant Collagen-Based Biomaterial Market Concentration Ratio (CR5 and HHI)
 Table 23. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
 Table 24. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
 Table 25. Global Recombinant Collagen-Based Biomaterial Sales by Type (2020-2025) & (Tons)
 Table 26. Global Recombinant Collagen-Based Biomaterial Sales by Type (2026-2031) & (Tons)
 Table 27. Global Recombinant Collagen-Based Biomaterial Revenue by Type (2020-2025) & (US$ Million)
 Table 28. Global Recombinant Collagen-Based Biomaterial Revenue by Type (2026-2031) & (US$ Million)
 Table 29. Global Recombinant Collagen-Based Biomaterial ASP by Type (2020-2031) & (US$/Ton)
 Table 30. Technical Specifications by Key Product Type
 Table 31. Global Recombinant Collagen-Based Biomaterial Sales by Application (2020-2025) & (Tons)
 Table 32. Global Recombinant Collagen-Based Biomaterial Sales by Application (2026-2031) & (Tons)
 Table 33. Recombinant Collagen-Based Biomaterial High-Growth Sectors Demand CAGR (2024-2031)
 Table 34. Global Recombinant Collagen-Based Biomaterial Revenue by Application (2020-2025) & (US$ Million)
 Table 35. Global Recombinant Collagen-Based Biomaterial Revenue by Application (2026-2031) & (US$ Million)
 Table 36. Global Recombinant Collagen-Based Biomaterial ASP by Application (2020-2031) & (US$/Ton)
 Table 37. Top Customers by Region
 Table 38. Top Customers by Application
 Table 39. North America Recombinant Collagen-Based Biomaterial Growth Accelerators and Market Barriers
 Table 40. North America Recombinant Collagen-Based Biomaterial Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 41. North America Recombinant Collagen-Based Biomaterial Sales (Tons) by Country (2020 VS 2024 VS 2031)
 Table 42. Europe Recombinant Collagen-Based Biomaterial Growth Accelerators and Market Barriers
 Table 43. Europe Recombinant Collagen-Based Biomaterial Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 44. Europe Recombinant Collagen-Based Biomaterial Sales (Tons) by Country (2020 VS 2024 VS 2031)
 Table 45. Asia-Pacific Recombinant Collagen-Based Biomaterial Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Asia-Pacific Recombinant Collagen-Based Biomaterial Sales (Tons) by Country (2020 VS 2024 VS 2031)
 Table 47. Asia-Pacific Recombinant Collagen-Based Biomaterial Growth Accelerators and Market Barriers
 Table 48. Southeast Asia Recombinant Collagen-Based Biomaterial Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 49. Central and South America Recombinant Collagen-Based Biomaterial Investment Opportunities and Key Challenges
 Table 50. Central and South America Recombinant Collagen-Based Biomaterial Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 51. Middle East and Africa Recombinant Collagen-Based Biomaterial Investment Opportunities and Key Challenges
 Table 52. Middle East and Africa Recombinant Collagen-Based Biomaterial Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 53. Evonik Industries Corporation Information
 Table 54. Evonik Industries Description and Major Businesses
 Table 55. Evonik Industries Product Models, Descriptions and Specifications
 Table 56. Evonik Industries Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 57. Evonik Industries Sales Value Proportion by Product in 2024
 Table 58. Evonik Industries Sales Value Proportion by Application in 2024
 Table 59. Evonik Industries Sales Value Proportion by Geographic Area in 2024
 Table 60. Evonik Industries Recombinant Collagen-Based Biomaterial SWOT Analysis
 Table 61. Evonik Industries Recent Developments
 Table 62. Trautec Corporation Information
 Table 63. Trautec Description and Major Businesses
 Table 64. Trautec Product Models, Descriptions and Specifications
 Table 65. Trautec Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 66. Trautec Sales Value Proportion by Product in 2024
 Table 67. Trautec Sales Value Proportion by Application in 2024
 Table 68. Trautec Sales Value Proportion by Geographic Area in 2024
 Table 69. Trautec Recombinant Collagen-Based Biomaterial SWOT Analysis
 Table 70. Trautec Recent Developments
 Table 71. Genemedicine Corporation Information
 Table 72. Genemedicine Description and Major Businesses
 Table 73. Genemedicine Product Models, Descriptions and Specifications
 Table 74. Genemedicine Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 75. Genemedicine Sales Value Proportion by Product in 2024
 Table 76. Genemedicine Sales Value Proportion by Application in 2024
 Table 77. Genemedicine Sales Value Proportion by Geographic Area in 2024
 Table 78. Genemedicine Recombinant Collagen-Based Biomaterial SWOT Analysis
 Table 79. Genemedicine Recent Developments
 Table 80. FibroGen Corporation Information
 Table 81. FibroGen Description and Major Businesses
 Table 82. FibroGen Product Models, Descriptions and Specifications
 Table 83. FibroGen Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 84. FibroGen Sales Value Proportion by Product in 2024
 Table 85. FibroGen Sales Value Proportion by Application in 2024
 Table 86. FibroGen Sales Value Proportion by Geographic Area in 2024
 Table 87. FibroGen Recombinant Collagen-Based Biomaterial SWOT Analysis
 Table 88. FibroGen Recent Developments
 Table 89. CollPlant Corporation Information
 Table 90. CollPlant Description and Major Businesses
 Table 91. CollPlant Product Models, Descriptions and Specifications
 Table 92. CollPlant Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 93. CollPlant Sales Value Proportion by Product in 2024
 Table 94. CollPlant Sales Value Proportion by Application in 2024
 Table 95. CollPlant Sales Value Proportion by Geographic Area in 2024
 Table 96. CollPlant Recombinant Collagen-Based Biomaterial SWOT Analysis
 Table 97. CollPlant Recent Developments
 Table 98. Geltor Corporation Information
 Table 99. Geltor Description and Major Businesses
 Table 100. Geltor Product Models, Descriptions and Specifications
 Table 101. Geltor Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 102. Geltor Recent Developments
 Table 103. Modern Meadow Corporation Information
 Table 104. Modern Meadow Description and Major Businesses
 Table 105. Modern Meadow Product Models, Descriptions and Specifications
 Table 106. Modern Meadow Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 107. Modern Meadow Recent Developments
 Table 108. Key Raw Materials Distribution
 Table 109. Raw Materials Key Suppliers
 Table 110. Critical Raw Material Supplier Concentration (2024) & Risk Index
 Table 111. Milestones in Production Technology Evolution
 Table 112. Distributors List
 Table 113. Market Trends and Market Evolution
 Table 114. Market Drivers and Opportunities
 Table 115. Market Challenges, Risks, and Restraints
 Table 116. Research Programs/Design for This Report
 Table 117. Key Data Information from Secondary Sources
 Table 118. Key Data Information from Primary Sources


List of Figures
 Figure 1. Recombinant Collagen-Based Biomaterial Product Picture
 Figure 2. Global Recombinant Collagen-Based Biomaterial Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 3. Medical Grade Recombinant Collagen Product Picture
 Figure 4. Cosmetic Grade Recombinant Collagen Product Picture
 Figure 5. Food Grade Recombinant Collagen Product Picture
 Figure 6. Others Product Picture
 Figure 7. Global Recombinant Collagen-Based Biomaterial Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 8. Medical Industry
 Figure 9. Cosmetic Industry
 Figure 10. Food Industry
 Figure 11. Others
 Figure 12. Recombinant Collagen-Based Biomaterial Report Years Considered
 Figure 13. Global Recombinant Collagen-Based Biomaterial Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 14. Global Recombinant Collagen-Based Biomaterial Revenue (2020-2031) & (US$ Million)
 Figure 15. Global Recombinant Collagen-Based Biomaterial Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Figure 16. Global Recombinant Collagen-Based Biomaterial Revenue Market Share by Region (2020-2031)
 Figure 17. Global Recombinant Collagen-Based Biomaterial Sales (2020-2031) & (Tons)
 Figure 18. Global Recombinant Collagen-Based Biomaterial Sales (CAGR) by Region (2020-2031) (Tons)
 Figure 19. Global Recombinant Collagen-Based Biomaterial Sales Market Share by Region (2020-2031)
 Figure 20. Global Recombinant Collagen-Based Biomaterial Capacity, Production and Utilization (2020-2031) & (Tons)
 Figure 21. Global Recombinant Collagen-Based Biomaterial Production Trend by Region (2020-2031) (Tons)
 Figure 22. Global Recombinant Collagen-Based Biomaterial Production Market Share by Region (2020-2031)
 Figure 23. Production Capacity Enablers & Constraints
 Figure 24. Recombinant Collagen-Based Biomaterial Production Growth Rate in North America (2020-2031) & (Tons)
 Figure 25. Recombinant Collagen-Based Biomaterial Production Growth Rate in Europe (2020-2031) & (Tons)
 Figure 26. Recombinant Collagen-Based Biomaterial Production Growth Rate in China (2020-2031) & (Tons)
 Figure 27. Recombinant Collagen-Based Biomaterial Production Growth Rate in Japan (2020-2031) & (Tons)
 Figure 28. Top 5 and Top 10 Manufacturers Recombinant Collagen-Based Biomaterial Sales Volume Market Share in 2024
 Figure 29. Global Recombinant Collagen-Based Biomaterial Revenue Market Share Ranking (2024)
 Figure 30. Tier Distribution by Revenue Contribution (2020 VS 2024)
 Figure 31. Medical Grade Recombinant Collagen Revenue Market Share by Manufacturer in 2024
 Figure 32. Cosmetic Grade Recombinant Collagen Revenue Market Share by Manufacturer in 2024
 Figure 33. Food Grade Recombinant Collagen Revenue Market Share by Manufacturer in 2024
 Figure 34. Others Revenue Market Share by Manufacturer in 2024
 Figure 35. Type Eight Revenue Market Share by Manufacturer in 2024
 Figure 36. Type Nine Revenue Market Share by Manufacturer in 2024
 Figure 37. Global Recombinant Collagen-Based Biomaterial Sales Market Share by Type (2020-2031)
 Figure 38. Global Recombinant Collagen-Based Biomaterial Revenue Market Share by Type (2020-2031)
 Figure 39. Global Recombinant Collagen-Based Biomaterial Sales Market Share by Application (2020-2031)
 Figure 40. Global Recombinant Collagen-Based Biomaterial Revenue Market Share by Application (2020-2031)
 Figure 41. North America Recombinant Collagen-Based Biomaterial Sales YoY (2020-2031) & (Tons)
 Figure 42. North America Recombinant Collagen-Based Biomaterial Revenue YoY (2020-2031) & (US$ Million)
 Figure 43. North America Top 5 Manufacturers Recombinant Collagen-Based Biomaterial Sales Revenue (US$ Million) in 2024
 Figure 44. North America Recombinant Collagen-Based Biomaterial Sales Volume (Tons) by Type (2020- 2031)
 Figure 45. North America Recombinant Collagen-Based Biomaterial Sales Revenue (US$ Million) by Type (2020 - 2031)
 Figure 46. North America Recombinant Collagen-Based Biomaterial Sales Volume (Tons) by Application (2020-2031)
 Figure 47. North America Recombinant Collagen-Based Biomaterial Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 48. US Recombinant Collagen-Based Biomaterial Revenue (2020-2031) & (US$ Million)
 Figure 49. Canada Recombinant Collagen-Based Biomaterial Revenue (2020-2031) & (US$ Million)
 Figure 50. Mexico Recombinant Collagen-Based Biomaterial Revenue (2020-2031) & (US$ Million)
 Figure 51. Europe Recombinant Collagen-Based Biomaterial Sales YoY (2020-2031) & (Tons)
 Figure 52. Europe Recombinant Collagen-Based Biomaterial Revenue YoY (2020-2031) & (US$ Million)
 Figure 53. Europe Top 5 Manufacturers Recombinant Collagen-Based Biomaterial Sales Revenue (US$ Million) in 2024
 Figure 54. Europe Recombinant Collagen-Based Biomaterial Sales Volume (Tons) by Type (2020-2031)
 Figure 55. Europe Recombinant Collagen-Based Biomaterial Sales Revenue (US$ Million) by Type (2020-2031)
 Figure 56. Europe Recombinant Collagen-Based Biomaterial Sales Volume (Tons) by Application (2020-2031)
 Figure 57. Europe Recombinant Collagen-Based Biomaterial Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 58. Germany Recombinant Collagen-Based Biomaterial Revenue (2020-2031) & (US$ Million)
 Figure 59. France Recombinant Collagen-Based Biomaterial Revenue (2020-2031) & (US$ Million)
 Figure 60. U.K. Recombinant Collagen-Based Biomaterial Revenue (2020-2031) & (US$ Million)
 Figure 61. Italy Recombinant Collagen-Based Biomaterial Revenue (2020-2031) & (US$ Million)
 Figure 62. Russia Recombinant Collagen-Based Biomaterial Revenue (2020-2031) & (US$ Million)
 Figure 63. Asia-Pacific Recombinant Collagen-Based Biomaterial Sales YoY (2020-2031) & (Tons)
 Figure 64. Asia-Pacific Recombinant Collagen-Based Biomaterial Revenue YoY (2020-2031) & (US$ Million)
 Figure 65. Asia-Pacific Top 8 Manufacturers Recombinant Collagen-Based Biomaterial Sales Revenue (US$ Million) in 2024
 Figure 66. Asia-Pacific Recombinant Collagen-Based Biomaterial Sales Volume (Tons) by Type (2020- 2031)
 Figure 67. Asia-Pacific Recombinant Collagen-Based Biomaterial Sales Revenue (US$ Million) by Type (2020- 2031)
 Figure 68. Asia-Pacific Recombinant Collagen-Based Biomaterial Sales Volume (Tons) by Application (2020-2031)
 Figure 69. Asia-Pacific Recombinant Collagen-Based Biomaterial Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 70. Indonesia Recombinant Collagen-Based Biomaterial Revenue (2020-2031) & (US$ Million)
 Figure 71. Japan Recombinant Collagen-Based Biomaterial Revenue (2020-2031) & (US$ Million)
 Figure 72. South Korea Recombinant Collagen-Based Biomaterial Revenue (2020-2031) & (US$ Million)
 Figure 73. China Taiwan Recombinant Collagen-Based Biomaterial Revenue (2020-2031) & (US$ Million)
 Figure 74. India Recombinant Collagen-Based Biomaterial Revenue (2020-2031) & (US$ Million)
 Figure 75. Central and South America Recombinant Collagen-Based Biomaterial Sales YoY (2020-2031) & (Tons)
 Figure 76. Central and South America Recombinant Collagen-Based Biomaterial Revenue YoY (2020-2031) & (US$ Million)
 Figure 77. Central and South America Top 5 Manufacturers Recombinant Collagen-Based Biomaterial Sales Revenue (US$ Million) in 2024
 Figure 78. Central and South America Recombinant Collagen-Based Biomaterial Sales Volume (Tons) by Type (2021-2031)
 Figure 79. Central and South America Recombinant Collagen-Based Biomaterial Sales Revenue (US$ Million) by Type (2020-2031)
 Figure 80. Central and South America Recombinant Collagen-Based Biomaterial Sales Volume (Tons) by Application (2020-2031)
 Figure 81. Central and South America Recombinant Collagen-Based Biomaterial Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 82. Brazil Recombinant Collagen-Based Biomaterial Revenue (2020-2025) & (US$ Million)
 Figure 83. Argentina Recombinant Collagen-Based Biomaterial Revenue (2020-2025) & (US$ Million)
 Figure 84. Middle East, and Africa Recombinant Collagen-Based Biomaterial Sales YoY (2020-2031) & (Tons)
 Figure 85. Middle East and Africa Recombinant Collagen-Based Biomaterial Revenue YoY (2020-2031) & (US$ Million)
 Figure 86. Middle East and Africa Top 5 Manufacturers Recombinant Collagen-Based Biomaterial Sales Revenue (US$ Million) in 2024
 Figure 87. Middle East and Africa Recombinant Collagen-Based Biomaterial Sales Volume (Tons) by Type (2021-2031)
 Figure 88. South America Recombinant Collagen-Based Biomaterial Sales Revenue (US$ Million) by Type (2020-2031)
 Figure 89. Middle East and Africa Recombinant Collagen-Based Biomaterial Sales Volume (Tons) by Application (2020-2031)
 Figure 90. Middle East and Africa Recombinant Collagen-Based Biomaterial Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 91. GCC Countries Recombinant Collagen-Based Biomaterial Revenue (2020-2025) & (US$ Million)
 Figure 92. Turkey Recombinant Collagen-Based Biomaterial Revenue (2020-2025) & (US$ Million)
 Figure 93. Egypt Recombinant Collagen-Based Biomaterial Revenue (2020-2025) & (US$ Million)
 Figure 94. South Africa Recombinant Collagen-Based Biomaterial Revenue (2020-2025) & (US$ Million)
 Figure 95. Recombinant Collagen-Based Biomaterial Industry Chain Mapping
 Figure 96. Regional Recombinant Collagen-Based Biomaterial Manufacturing Base Distribution (%)
 Figure 97. Recombinant Collagen-Based Biomaterial Production Process
 Figure 98. Regional Recombinant Collagen-Based Biomaterial Production Cost Structure
 Figure 99. Channels of Distribution (Direct Vs Distribution)
 Figure 100. Bottom-up and Top-down Approaches for This Report
 Figure 101. Data Triangulation
 Figure 102. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$4900

This license allows only one user to access the PDF.
Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Bioinformatics Barcelona

SIMILAR REPORTS

Global Recombinant Collagen for Cosmetics Market Research Report 2024
Global Restructured Collagen for Skin Care Market Research Report 2024
Global Recombinant Humanized Collagen Type III Market Research Report 2024
Recombinant Collagen Market
Global Reconstituted Collagen Dressing Market Research Report 2024
Global Medical Grade Collagen Market Research Report 2024
Global Collagen Gel Market Research Report 2024
Global Recombinant Human Collagen Market Research Report 2025
Global Biological Collagen Market Research Report 2024
Global Porcine Collagen Membrane Market Research Report 2024
Global Recombinant Type III Collagen Market Research Report 2024
Global Medical Recombinant Collagen Sterile Dressing Market Research Report 2024
Tissue Engineered Collagen Biomaterials Market
Global Reconstituted Human Collagen Market Research Report 2024
Global Cell Culture Grade Collagen Market Research Report 2025
Medical and Research Grade Collagen Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Lyophilized Fiber of Recombinant Collagen Market Research Report 2024
Global Recombinant Collagen Microcarriers Market Research Report 2024
Global Collagen based Implants Market Research Report 2024
Global ECM derived Biomaterials Market Research Report 2024

RELATED REPORTS

Global Pharmacy Chatbot Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-10T20319
Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global Inline Pharmaceutical Packaging Leak Detection System Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-6Q20319
Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global Radiological Marker Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-35Z19949
Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global Pharmaceutical Biomanufacturing Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-26E19785
Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions